Ingevity [NGVT] vs Linde plc [LIN] Detailed Stock Comparison

Ingevity Corporation

NYSE
Loading...

Linde plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Ingevity Corporation wins in 6 metrics, Linde plc wins in 14 metrics, with 0 ties. Linde plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ingevity Corporation Linde plc Better
P/E Ratio (TTM) 12.96 34.73 Ingevity Corporation
Price-to-Book Ratio 89.27 6.16 Linde plc
Debt-to-Equity Ratio 4,184.18 70.63 Linde plc
PEG Ratio -0.02 26.03 Linde plc
EV/EBITDA 10.59 19.48 Ingevity Corporation
Profit Margin (TTM) -14.31% 20.30% Linde plc
Operating Margin (TTM) 15.21% 28.17% Linde plc
EBITDA Margin (TTM) 15.21% 28.17% Linde plc
Return on Equity -133.66% 17.82% Linde plc
Return on Assets (TTM) 8.91% 7.17% Ingevity Corporation
Free Cash Flow (TTM) $273.50M $5.09B Linde plc
Dividend Yield N/A 1.49% N/A
1-Year Return 63.94% 6.44% Ingevity Corporation
Price-to-Sales Ratio (TTM) 2.26 6.93 Ingevity Corporation
Enterprise Value $3.79B $259.94B Linde plc
EV/Revenue Ratio 3.25 7.65 Ingevity Corporation
Gross Profit Margin (TTM) 34.42% 48.12% Linde plc
Revenue per Share (TTM) $32 $72 Linde plc
Earnings per Share (Diluted) $-4.15 $14.63 Linde plc
Beta (Stock Volatility) 1.28 0.79 Linde plc
Short % of Float 4.96% 1.53% Linde plc

Ingevity Corporation vs Linde plc Stock Performance Analysis

Loading Price Chart...

NGVT
LIN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ingevity Corporation-0.30%-2.84%-9.24%-5.22%27.46%11.45%
Linde plc2.35%-0.06%2.84%1.17%24.05%18.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ingevity Corporation63.94%30.90%-20.86%113.67%155.92%155.92%
Linde plc6.44%38.07%65.97%351.46%393.45%799.17%

Performance & Financial Health Analysis: Ingevity Corporation vs Linde plc

MetricNGVTLIN
Market Information
Market Cap i$2.66B$236.47B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i178,2241,804,155
90 Day Avg. Volume i306,2652,343,675
Last Close$66.97$507.57
52 Week Range$39.74 - $79.29$387.78 - $521.28
% from 52W High-15.54%-2.63%
All-Time High$120.41 (Feb 18, 2019)$521.28 (May 01, 2026)
% from All-Time High-44.38%-2.63%
Growth Metrics
Quarterly Revenue Growth-0.15%0.06%
Quarterly Earnings Growth-0.15%-0.11%
Financial Health
Profit Margin (TTM) i-0.14%0.20%
Operating Margin (TTM) i0.15%0.28%
Return on Equity (TTM) i-1.34%0.18%
Debt to Equity (MRQ) i4,184.1870.63
Cash & Liquidity
Book Value per Share (MRQ)$0.84$82.48
Cash per Share (MRQ)$2.21$10.91
Operating Cash Flow (TTM) i$331.20M$10.35B
Levered Free Cash Flow (TTM) i$306.49M$4.79B
Dividends
Last 12-Month Dividend Yield iN/A1.49%
Last 12-Month Dividend iN/A$7.60

Valuation & Enterprise Metrics Analysis: Ingevity Corporation vs Linde plc

MetricNGVT (Apr 24, 2026)LIN (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i12.9634.73
Forward P/E i12.6226.03
PEG Ratio i-0.0226.03
Price to Sales (TTM) i2.266.93
Price to Book (MRQ) i89.276.16
Market Capitalization
Market Capitalization i$2.66B$236.47B
Enterprise Value i$3.79B$259.94B
Enterprise Value Metrics
Enterprise to Revenue i3.257.65
Enterprise to EBITDA i10.5919.48
Risk & Other Metrics
Beta i1.280.79
Book Value per Share (MRQ) i$0.84$82.48

Financial Statements Comparison: Ingevity Corporation vs Linde plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNGVT (2025)LIN (2025)
Revenue/Sales i1.17B33.99B
Cost of Goods Sold i706.10M17.39B
COGS % of Revenue i60.5%51.2%
Gross Profit i461.50M16.60B
Gross Margin i39.5%48.8%
Research & Development i28.40M147.00M
Operating Income (EBIT) i261.90M9.25B
Operating Margin i22.4%27.2%
EBITDA i345.90M13.55B
EBITDA Margin i29.6%39.9%
Pre-Tax Income i-142.10M8.90B
Pre-Tax Income % of Revenue i-12.2%26.2%
Income Tax i8.20M1.99B
Income Tax % of Revenue i0.7%5.9%
Net Income (Profit) i-167.10M7.06B
Profit Margin i-14.3%20.8%

Balance Sheet & Liquidity Metrics

MetricNGVT (2025)LIN (2025)
Cash & Equivalents i78.10M5.06B
Total Current Assets i454.20M13.33B
Total Current Assets % of Revenue i38.9%39.2%
Total Current Liabilities i341.30M15.20B
Total Current Liabilities % of Revenue i29.2%44.7%
Long-Term Debt i1.18B21.50B
Long-Term Debt % of Revenue i101.4%63.3%
Total Shareholders Equity i29.70M39.74B
Retained Earnings i404.90M16.61B
Retained Earnings % of Revenue i34.7%48.9%
Property, Plant & Equipment i65.10M12.84B

Cash Flow Statement Comparison

MetricNGVT (2025)LIN (2025)
Operating Cash Flow i13.40M10.44B
Operating Cash Flow % of Revenue i1.1%30.7%
Capital Expenditures iN/AN/A
Free Cash Flow i273.50M5.09B
FCF Margin i23.4%15.0%
Debt Repayment i-483.60M-2.28B
Common Stock Repurchase i-56.30M-4.60B

Short Interest & Institutional Ownership Analysis

MetricNGVTLIN
Shares Short i1.25M7.08M
Short Ratio i3.122.61
Short % of Float i4.96%1.53%
Shares Outstanding i35.49M463.68M
Float Shares i35.06M461.73M
% Held by Insiders i0.77%0.26%
% Held by Institutions i108.56%87.78%
% Held by Public i-9.33%11.96%

Dividend Analysis & Yield Comparison: Ingevity Corporation vs Linde plc

MetricNGVTLIN
Last 12-Month Dividend iN/A$7.60
Last 12-Month Dividend Yield iN/A1.49%
3-Year Avg Annual Dividend iN/A$6.08
3-Year Avg Dividend Yield iN/A0.33%
3-Year Total Dividends iN/A$18.24
Ex-Dividend DateN/AMar 11, 2026